Genome editing raises old questions, but CRISPR arose in a political landscape that vastly differs from the early aughts.

Clinicians diagnosing and treating potentially trafficked patients with co-occurring addiction and mental illness should guard against expressing negative biases.

Research and training are needed so that physicians are able to identify human trafficking victims and refer them to appropriate trauma-informed treatment.

During or after conflict, a clinician might be required to provide evidence to an official investigatory body or court.

After years of funding disease-specific treatment, donation trends have shifted to support broader health systems infrastructure development. A remaining challenge is how to sustain antiretroviral therapy (ART) for patients in resource-poor regions.